The guidance describes FDA’s thinking on recommended documentation included in premarket submissions for FDA’s evaluation of the safety and effectiveness of device software functions.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/7HFDb6x
No comments:
Post a Comment